
NASDAQFinancial ServicesAsset Management
Latest quote
$2.81
−$0.24 · -7.87%
Cypherpunk Technologies Inc. is a privacy-focused technology company that combines a digital asset treasury strategy centered on Zcash (ZEC) with the development of novel cancer therapies through its subsidiary. The company's mission is to advance technologies that guarantee privacy for individuals on the internet, with a primary focus on investing in, accelerating the adoption of, and strengthening the ecosystem of Zcash, a privacy-preserving digital currency.
Latest quote
$2.81
−$0.24 · -7.87%
After-hours
$2.879
+$0.069 · +2.46%
Oct 8, 7:56 PM ET
Regular session · ET · Market data may be delayed.
Cypherpunk Technologies Inc. is a privacy-focused technology company that combines a digital asset treasury strategy centered on Zcash (ZEC) with the development of novel cancer therapies through its subsidiary. The company's mission is to advance technologies that guarantee privacy for individuals on the internet, with a primary focus on investing in, accelerating the adoption of, and strengthening the ecosystem of Zcash, a privacy-preserving digital currency.
Day range
Current $2.81
52-week range
Current $2.81
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
43
Fair Value
Sentiment
47
Mixed
Risk
63
High Risk
Momentum
20
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Cypherpunk Technologies Inc. is a privacy-focused technology company that combines a digital asset treasury strategy centered on Zcash (ZEC) with the development of novel cancer therapies through its subsidiary. The company's mission is to advance technologies that guarantee privacy for individuals on the internet, with a primary focus on investing in, accelerating the adoption of, and strengthening the ecosystem of Zcash, a privacy-preserving digital currency.
Day range
Current $2.81
52-week range
Current $2.81
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 1.5M USD |
| Cost of goods sold | — | — | 427K USD | — | — |
| Gross profit | — | — | −427K USD | — | 1.5M USD |
| Research and development | 25.67M USD | 57.21M USD | 73.23M USD | 44.97M USD | 32.16M USD |
| Selling, general, and administrative | 10.87M USD | 12.85M USD | 13.38M USD | 11.8M USD | 10.77M USD |
| Operating expenses | 36.54M USD | 70.06M USD | 86.61M USD | 56.76M USD | 42.93M USD |
| Interest income | 916K USD | 3.13M USD | 4.03M USD | 925K USD | 9K USD |
| Interest expense | 24K USD | — | — | 54K USD | 41K USD |
| Depreciation and amortization | — | 5K USD | 15K USD | 16K USD | 29K USD |
| Operating income | −36.54M USD | −70.06M USD | −87.04M USD | −56.76M USD | −41.43M USD |
| Net income | 4.82M USD | −67.56M USD | −81.41M USD | −54.6M USD | −40.59M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$5.50
95.73% upsideFunds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.